HOSPITAL TRANG PUBLIC COMPANY LIMITED Shareholders’ Equities Shareholders’ Equities as of 31 December 2015 ,31 December 2016 and 30 July 2017 were Baht 271.58 million, 350.97 million and 430.80 million
% respectively, which decreased by 4.0%. The decrease was primarily due to the more effective internal control system of The Company. Financing Costs The Company and its subsidiary ‘s financing costs in relation
’ Equities as of 31 December 2016 and 30 September 2017 were Baht 350.97 million and 835.04 million respectively. The proportion of Shareholders' Equity increased from the share capital and capital in excess
2018 Page 17/21 Overview of the Stock Exchange of Thailand In line with global equities, Thai stocks saw another year of unusual volatility in 2018 of which investor confidence was affected considerably
540 -36% EBITDA Margin (%) 9.0% 7.3% 4.7% -4.3% -2.6% 9.2% 5.9% -3.2% Net Profit 322 145 71 -78% -51% 591 216 -63% EPS (Baht/Share) (1) 0.44 0.20 0.07 -84% -65% 0.80 0.21 -74% Adjusted EBITDA(2) 323 345
% 227 EBITDA Margin (%) 8.9% 4.7% 4.1% -4.9% -0.6% 9.1% 5.3% -3.8% 1.3% Net Profit 204 71 55 -73% -23% 795 270 -66% 937 EPS (Baht/Share) 0.28 0.07 0.05 -81% -23% 1.07 0.30 -72% (1.42) Stock Gain/(Loss
million which comprised of cash and short-term investment amounted to THB 3,882 million, with total liabilities of THB 3,069 million and total equities of THB 9,730 million. In this regard, the company’s
investment amounted to THB 3,890 million; with total liabilities of THB 3,528 million; and total equities of THB 9,265 million. In this regard, the company remains strong in a financial position with low debt
% from 1Q2019. In 1Q2020, the Company recorded share of profit from investment in Joint Ventures, Thai Ethoxylates Company Limited (TEX) and GGC KTIS Bio Industrial Company Limited (GKBI), at THB 62